Antibodies

Development and validation of a biomonitoring method to measure As, Cr, and Ni in human urine samples by ICP-UCT-MS

by
Development and validation of a biomonitoring method to measure As, Cr, and Ni in human urine samples by ICP-UCT-MS
We developed an inductively coupled plasma mass spectrometry (ICP-MS) method utilizing Universal Cell Technology (UCT) with a PerkinElmer NexION ICP-MS, to measure arsenic (As), chromium (Cr), and nickel (Ni) in human urine samples. The developments of the UCT allowed us to increase the calibration vary to make the method relevant for each low concentrations of biomonitoring purposes and excessive concentrations which may be noticed from acute exposures and emergency response.
Our method analyzes As and Ni in kinetic vitality discrimination (KED) mode with helium (He) gasoline, and Cr in dynamic response cell (DRC) mode with ammonia (NH3) gasoline. The mixture of these components is difficult as a result of a carbon supply, ethanol (EtOH), is required for normalization of As ionization in urine samples, which creates a spectral overlap (40Ar12C+) on 52Cr. This method moreover improved lab effectivity by combining components from two of our beforehand printed strategies(Jarrett et al., 2007; Quarles et al., 2014) permitting us to measure Cr and Ni concentrations in urine samples collected as half of the National Health and Nutrition Examination Survey (NHANES) starting with the 2017-2018 survey cycle.
We current our rigorous validation of the method selectivity and accuracy utilizing National Institute of Standards and Technology (NIST) Standard Reference Materials (SRM), precision utilizing in-house ready high quality management supplies, and a dialogue of the use of a modified UCT, a BioUCell, to deal with an ion transmission phenomenon we noticed on the NexION 300 platform when utilizing increased elemental concentrations and excessive cell gasoline pressures. Specimens had been collected at 130,012 (64.4%) hospitalizations with any antibiotic use, and a minimum of one bacterial organism was remoted at 35.1% of these stays. Frequency of bacterial isolation assorted extensively by analysis class and antibiotic group. Under more and more lenient standards, 10.2% to 31.4% of 974,733 antibiotic days-of-therapy may very well be linked to a potential bacterial pathogen.

Rational choice of a biomarker panel focusing on unmet scientific wants in viral kidney damage

The pipeline of biomarker translation from bench to bedside is difficult and restricted biomarkers have been adopted to routine scientific care. Ideally, biomarker analysis and improvement ought to be pushed by unmet scientific wants in well being care. To information researchers, scientific chemists and clinicians in their biomarker analysis, the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) has developed a structured questionnaire in which the scientific gaps in present scientific pathways are recognized and fascinating efficiency specs are predefined. In kidney damage, the excessive prevalence of the syndrome acute kidney damage (AKI) in the hospital setting has a important influence on morbidity, affected person survival and well being care prices, however the use of biomarkers indicating early kidney damage in day by day affected person care stays restricted.

Routinely, medical labs measure serum creatinine, which is a purposeful biomarker, insensitive for detecting early kidney harm and can not distinguish between renal and prerenal AKI. The perceived unmet scientific wants in kidney damage had been recognized via the EFLM questionnaire. Nephrologists inside our tertiary care hospital emphasised that biomarkers are wanted for (1) early analysis of in-hospital AKI after a medical insult and in critically in poor health sufferers, (2) danger stratification for kidney damage prior to a scheduled (elective) intervention, (3) kidney damage monitoring in sufferers scheduled to obtain nephrotoxic medicine and after kidney transplantation and (4) differentiation between prerenal AKI and structural kidney harm.

The biomarker search and choice technique resulted in a rational choice of an eleven-protein urinary panel for kidney damage that concentrate on these scientific wants. To assess the scientific utility of the proposed biomarker panel in kidney damage, a multiplexed LC-MS check is now in improvement for the meant translational analysis. The rugged method detection limits, calculated from measurements in greater than 60 runs, for As, Cr, and Ni are 0.23 μg L-1, 0.19 μg L-1, and 0.31 μg L-1, respectively.

Development and validation of a biomonitoring method to measure As, Cr, and Ni in human urine samples by ICP-UCT-MS

Different approaches to enhance cohort identification utilizing digital well being data: X-linked hypophosphatemia for example

Electronic Health Records (EHRs) symbolize a supply of excessive worth knowledge which is commonly underutilized as a result of exploiting the knowledge contained therein requires specialised strategies unavailable to the tip person i.e. the doctor or the investigator. Here I describe 4 easy and sensible avenues that can permit the usual EHR finish person to establish affected person cohorts: the use of diagnostic codes from completely different worldwide catalogues; a search in studies from complementary assessments (e.g. radiographs or lab assessments) for any consequence of curiosity; a free textual content search; or a drug prescription search in the affected person’s digital prescription document.

This medical method is buying nice significance in the sector of uncommon ailments, and right here I display its utility with X-linked hypophosphatemia. The use of these 4 EHR questioning approaches makes discovering a cohort of sufferers of any situation or illness possible and manageable, and as soon as every case document is checked, a well-defined cohort could be assembled.

Goat IgG-PE conjugate (isotype control)
20011-PE 100 tests
EUR 225

Rat IgG-Biotin conjugate (isotype control) (Isotype control)
20005-B 100 ug
EUR 164

Rat IgG-FITC conjugate (isotype control) (Isotype control)
20005-F 100 ug
EUR 164

Rat IgG-HRP conjugate (isotype control) (Isotype control)
20005-HP 100 ug
EUR 164

Rat IgG-PE conjugate (isotype control) (Isotype control)
20005-PE 25 tests
EUR 202

Goat IgG (fc)-Biotin conjugate (isotype control)
20011-Fc-B 100 ug
EUR 164

Goat IgG (fc)-FITC conjugate (isotype control)
20011-Fc-F 100 ug
EUR 164

Goat IgG (fc)-HRP conjugate (isotype control)
20011-Fc-HP 100 ug
EUR 164

Goat F(ab')2 IgG Isotype Control
abx405076-05mg 0.5 mg
EUR 411

Rabbit IgG Isotype Control
abx125003-100ul 100 ul
EUR 203

Rabbit IgG Isotype Control
IC001-100ul 100ul
EUR 122

Mouse IgG Isotype Control
IC002-100ul 100ul
EUR 122

IgG Isotype Control antibody
10R-6524 50 ug
EUR 133
Description: Armenian Hamster monoclonal IgG Isotype Control antibody

IgG Isotype Control antibody
10R-6525 50 ug
EUR 133
Description: Syrian Hamster monoclonal IgG Isotype Control antibody

Rat IgG Isotype Control
31-AR15 10 mg
EUR 220
Description: Purified Rat IgG Isotype Control

Goat IgG (-ve control for flow cytometry) (isotype control)
20011-100 100 test
EUR 103

Goat IgG, purified (serum non-immune, isotype control)
20011-1 1 mg
EUR 141

Goat IgG, purified (serum non-immune, isotype control)
20011-25 25 mg
EUR 469

Goat IgG, purified (serum non-immune, isotype control)
20011-5 5 mg
EUR 286

Goat F(ab')2 IgG Isotype Control (FITC)
abx405077-100tests 100 tests
EUR 495

Goat F(ab')2 IgG Isotype Control (RPE)
abx405078-05ml 0.5 ml
EUR 537

Rat IgG purified (isotype control)
20005-1-200 0.5 ml
EUR 103

Rat IgG, purified (Isotype control)
20005-5 5 mg
EUR 286

Sheep IgG, purified (isotype control)
20006-1 1 mg
EUR 141

Rabbit IgG-biotinylated (isotype control)
20009-BT-1 1 mg
EUR 286

Hamster (Armenian) IgG Isotype Control
abx405028-025mg 0.25 mg
EUR 384

Hamster (Arnenian) IgG Isotype Control
abx405029-05mg 0.5 mg
EUR 592

Hamster (Syrian) IgG Isotype Control
abx405032-025mg 0.25 mg
EUR 384

Syrian Hamster IgG Isotype Control
SIGGA-100 100 µg
EUR 574.16

Syrian Hamster IgG Isotype Control
SIGGB-200 200 µg
EUR 472.24

Syrian Hamster IgG Isotype Control
SIGGF-200 200 µg
EUR 545.04

Syrian Hamster IgG Isotype Control
SIGGPE-100 100 µg
EUR 515.92

Syrian Hamster IgG Isotype Control
SIGGPP5.5-100 100 µg
EUR 676.08

Syrian Hamster IgG Isotype Control
SIGGPP5.5-25 25 µg
EUR 355.76

Syrian Hamster IgG Isotype Control
SIGGPU-500 500 µg
EUR 428.56

Rabbit IgG Isotype control, Concentrate
NG910C 0.5 ml
EUR 392

Armenian Hamster IgG Isotype control
AIGGA-100 100 µg
EUR 574.16

Armenian Hamster IgG Isotype control
AIGGA-25 25 µg
EUR 282.96

Armenian Hamster IgG Isotype control
AIGGB-200 200 µg
EUR 472.24

Armenian Hamster IgG Isotype control
AIGGB-50 50 µg
EUR 239.28

Armenian Hamster IgG Isotype control
AIGGF-200 200 µg
EUR 545.04

Armenian Hamster IgG Isotype control
AIGGF-50 50 µg
EUR 268.4

Armenian Hamster IgG Isotype control
AIGGPE-100 100 µg
EUR 515.92

Armenian Hamster IgG Isotype control
AIGGPE-25 25 µg
EUR 253.84

Armenian Hamster IgG Isotype control
AIGGPP-100 100 µg
EUR 574.16

Armenian Hamster IgG Isotype control
AIGGPP-25 25 µg
EUR 268.4

Armenian Hamster IgG Isotype control
AIGGPP5.5-100 100 µg
EUR 646.96

Armenian Hamster IgG Isotype control
AIGGPP5.5-25 25 µg
EUR 282.96

Armenian Hamster IgG Isotype control
AIGGPU-50 50 µg
EUR 195.6

Armenian Hamster IgG Isotype control
AIGGPU-500 500 µg
EUR 428.56

FITC Rabbit IgG - Isotype control
DB1000 100 tests
EUR 422

FITC Rabbit IgG - Isotype control
DB-1000 100 tests
EUR 422

IgG Isotype Control antibody (FITC)
61R-1136 50 ug
EUR 165
Description: Armenian Hamster monoclonal IgG Isotype Control antibody (FITC)

IgG Isotype Control antibody (PE)
61R-1337 200 ug
EUR 440
Description: Armenian Hamster monoclonal IgG Isotype Control antibody (PE)

IgG Isotype Control antibody (PE)
61R-1338 50 ug
EUR 181
Description: Syrian Hamster monoclonal IgG Isotype Control antibody (PE)

IgG Isotype Control antibody (biotin)
61R-1586 50 ug
EUR 165
Description: Armenian Hamster monoclonal IgG Isotype Control antibody (biotin)

IgG Isotype Control antibody (biotin)
61R-1587 50 ug
EUR 165
Description: Syrian Hamster monoclonal IgG Isotype Control antibody (biotin)

IgG Isotype Control antibody (allophycocyanin)
61R-1768 100 ug
EUR 349
Description: Armenian Hamster monoclonal IgG Isotype Control antibody (allophycocyanin)

IgG Isotype Control antibody (allophycocyanin)
61R-1769 50 ug
EUR 219
Description: Syrian Hamster monoclonal IgG Isotype Control antibody (allophycocyanin)

IgG Isotype Control antibody (FITC)
61R-1800 25 ug
EUR 205
Description: Rabbit polyclonal IgG Isotype Control antibody (FITC)

Donkey IgG (Control, non-immune, isotype control)
20028-1 1 mg
EUR 164

Goat IgG Control
GT15900 1 mg
EUR 166

Goat IgG control
31R-AG001 1 mg
EUR 127
Description: Goat Immunoglobulins Goat IgG control

Rabbit IgG Isotype Control APC Conjugate
APCCON 0.15 mg
EUR 261

Rabbit IgG Isotype Control FITC Conjugate
FITCCON 0.15 mg
EUR 261

Mouse IgG Isotype Control PerCP Conjugate
MPERCPCON 0.15 mg
EUR 261

Mouse IgG Isotype Control RPE Conjugate
MRPECON 0.15 mg
EUR 261

Rabbit IgG Isotype Control PerCP Conjugate
PERCPCON 0.15 mg
EUR 261

Rabbit IgG Isotype Control RPE Conjugate
RPECON 0.15 mg
EUR 261

Mouse IgG Isotype Control APC Conjugate
MAPCCON 0.15 mg
EUR 261

Mouse IgG Isotype Control FITC Conjugate
MFITCCON 0.15 mg
EUR 261

Hamster IgG, purified (Syrian, isotype control)
20003-1 1 mg
EUR 141

Hamster IgG, purified (Armenian, Isotype control)
20003-1AH 1 mg
EUR 263

Human IgG-HRP Conjugate (isotype control)
20007-1-HP 500 ug
EUR 202

Mouse IgG-Biotin conjugate (isotype control)
20008-B 50 Tests
EUR 164

Mouse IgG-Biotin conjugate (isotype control)
20008-BT-1 1 mg
EUR 164

Mouse IgG-FITC conjugate (isotype control)
20008-F 100 tests
EUR 164

Mouse IgG-HRP conjugate (isotype control)
20008-HP 50 Tests
EUR 164

Mouse IgG-PE conjugate (isotype control)
20008-PE 50 Tests
EUR 164

Rabbit IgG-FITC conjugate (isotype control)
20009-F 100 ug
EUR 164

Rabbit IgG-HRP conjugate (isotype control)
20009-HP 100 ug
EUR 164

Rabbit IgG-PE conjugate (isotype control)
20009-PE 100 tests
EUR 225

Hamster (Arnenian) IgG Isotype Control (FITC)
abx405030-01mg 0.1 mg
EUR 384

Hamster (Arnenian) IgG Isotype Control (RPE)
abx405031-01mg 0.1 mg
EUR 509

Hamster (Syrian) IgG Isotype Control (FITC)
abx405033-01mg 0.1 mg
EUR 398

Donkey IgG (non-immune, isotype control) IgG, purified
20015-10 10 mg
EUR 286

Llama IgG (Control, non-immune, isotype control, ELISA grade)
20030-1 1 mg
EUR 164

Camel IgG (Control, non-immune, isotype control, ELISA grade)
20031-1 1 mg
EUR 164

Alpaca IgG (Control, non-immune, isotype control, ELISA grade)
20032-1 1 mg
EUR 164

Goat IgG Control Sera
20011-250 0.5 ml
EUR 103

Hamster IgG-Biotin conjugate, isotype control (Syrian)
20003-1-B 100 test
EUR 164

Hamster IgG-Cy5 conjugate, isotype control (Syrian)
20003-1-Cy5 50 tests
EUR 225

Hamster IgG-FITC conjugate, isotype control (Syrian)
20003-1-F 100 tests
EUR 164

Hamster IgG-HRP conjugate, isotype control (Syrian)
20003-1-HP 100 tests
EUR 164

G. Pig IgG-Biotin conjugate (isotype control)
20004-B 100 ug
EUR 202

G. Pig IgG-FITC conjugate (isotype control)
20004-F 100 ug
EUR 202

G. Pig IgG-HRP conjugate (isotype control)
20004-HP 100 ug
EUR 202

Rat IgG Fab fragment, purified (isotype control)
20005-1-FAB 1 mg
EUR 164
The Children’s Health Exposure Analysis Resource (CHEAR) program permits researchers to increase their analysis targets by providing the evaluation of environmental exposures in their beforehand collected biospecimens. Samples are analyzed in one of CHEAR’s community of six laboratory hubs with the flexibility to assess a big selection of environmental chemical compounds. The means to assess inter-study variability is essential for researchers who need to mix datasets throughout research and laboratories.

Systematic Review of Approaches to Use of Neighborhood-Level Risk Factors With ClinicalData to Predict Clinical Risk and recomm

by
Systematic Review of Approaches to Use of Neighborhood-Level Risk Factors With ClinicalData to Predict Clinical Risk and recomm
Despite a large body of literature investigating how the environment influences health outcomes, most published work to date includes only a limited subset of the rich clinical and environmental data that is available and does not address how these data might best be used to predict clinical risk or expected impact of clinical interventions. Identify existing approaches to inclusion of a broad set of neighborhood-level risk factors with clinical data to predict clinical risk and recommend interventions. A systematic review of scientific literature published and indexed in PubMed, Web of Science, Association of Computing Machinery (ACM) and SCOPUS from 2010 through October 2020 was performed.
To be included, articles had to include search terms related to Electronic Health Record (EHR) data Neighborhood-Level Risk Factors (NLRFs), and Machine Learning (ML) Methods. Citations of relevant articles were also reviewed for additional articles for inclusion. Articles were reviewed and coded by two independent reviewers to capture key information including data sources, linkage of EHR to NRLFs, methods, and results. Articles were assessed for quality using a modified Quality Assessment Tool for Systematic Reviews of Observational Studies (QATSO).
 A total of 334 articles were identified for abstract review. 36 articles were identified for full review with 19 articles included in the final analysis. All but two of the articles included socio-demographic data derived from the U.S. Census and we found great variability in sources of NLRFs beyond the Census. The majority or the articles (14 of 19) included broader clinical (e.g. medications, labs and co-morbidities) and demographic information about the individual from the EHR in addition to the clinical outcome variable.
Half of the articles (10) had a stated goal to predict the outcome(s) of interest. While results of the studies reinforced the correlative association of NLRFs to clinical outcomes, only one article found that adding NLRFs into a model with other data added predictive power with the remainder concluding either that NLRFs were of mixed value depending on the model and outcome or that NLRFs added no predictive power over other data in the model. Only one article scored high on the quality assessment with 13 scoring moderate and 4 scoring low.
In spite of growing interest in combining NLRFs with EHR data for clinical prediction, we found limited evidence that NLRFs improve predictive power in clinical risk models. We found these data and methods are being used in four ways. First, early approaches to include broad NLRFs to predict clinical risk primarily focused on dimension reduction for feature selection or as a data preparation step to input into regression analysis. Second, more recent work incorporates NLRFs into more advanced predictive models, such as Neural Networks, Random Forest, and Penalized Lasso to predict clinical outcomes or predict value of interventions.
Third, studies that test how inclusion of NLRFs predict clinical risk have shown mixed results regarding the value of these data over EHR or claims data alone and this review surfaced evidence of potential quality challenges and biases inherent to this approach. Finally, NLRFs were used with unsupervised learning to identify underlying patterns in patient populations to recommend targeted interventions. Further access to computable, high quality data is needed along with careful study design, including sub-group analysis, to better determine how these data and methods can be used to support decision making in a clinical setting.
Systematic Review of Approaches to Use of Neighborhood-Level Risk Factors With ClinicalData to Predict Clinical Risk and recomm

Rapid online teaching: movement of animal science courses online during COVID-19. Case study: pedagogical decisions in transitioning animal science courses online

Traditionally, earning a degree in animal science requires many face-to-face, hands-on courses; however, the COVID-19 pandemic created a situation in which traditional delivery of these courses may not be feasible as they provide a health risk to our students, teaching assistants, and instructors alike. This examination of two pedagogically different courses and how each was transitioned to an online format highlights the types of teaching decisions that are required to effectively teach animal science in an online format. The Farm Animal Production Systems lab was an animal handling and production practices lab, and although the transition to online delivery did not allow for students to participate in traditional hands-on development of skills, various resources were utilized that still achieved the development of animal handling concepts that will prepare students for later courses and work with live animals.

Goat Anti Mouse IgG
E61I00501 100ug
EUR 343

Goat Anti-mouse IgG
STJ15100178 250 µg
EUR 283
Description: Biotinylated goat anti-mouse IgG enables detection of mouse IgG in enzyme immunoassays such as indirect ELISA.

Goat anti Mouse IgG
20-B9015G000-S0 10 ml
EUR 133
Description: Goat anti Mouse IgG antibody

Goat anti Mouse IgG
20-S8301G000-V0 10 ml
EUR 133
Description: Goat anti Mouse IgG antibody

Goat anti Mouse IgG
40-GM25S 100 ml
EUR 133
Description: Goat anti Mouse IgG secondary antibody

Goat anti Mouse IgG
40-S8301G000-S4 10 ml
EUR 133
Description: Goat anti Mouse IgG secondary antibody

Goat anti Mouse IgG
41-GM25 20 mg
EUR 184
Description: Goat anti Mouse IgG secondary antibody

Goat anti Mouse IgG
41R-1058 2 mg
EUR 149
Description: Goat anti Mouse IgG secondary antibody

Anti-Goat IgG antibody
STJ16101225 1 mg
EUR 191

Anti-Goat IgG antibody
STJ16101226 1.2 mg
EUR 229

Anti-Goat IgG antibody
STJ16101227 1.2 mg
EUR 282

Goat Anti-Mouse IgG Antibody (TRITC)
abx019213-01ml 0.1 ml
EUR 244

Mouse Anti-Goat IgG (Fc) Antibody
abx023336-1mg 1 mg
EUR 370

Goat Anti-Mouse IgG (Fc) Antibody
abx023402-5mg 5 mg
EUR 495

Goat Anti-Mouse IgG (Fc) Antibody
abx023405-2mg 2 mg
EUR 439

Goat Anti-Mouse IgG (Fc) Antibody
abx023407-2mg 2 mg
EUR 411

Goat Anti-Mouse IgG (Fc) Antibody
abx023543-1mg 1 mg
EUR 523

Goat Anti-Mouse IgG Antibody (HRP)
20-abx400001
  • EUR 189.00
  • EUR 112.00
  • EUR 272.00
  • 100 ug
  • 10 ug
  • 1 mg

Goat Anti-Mouse IgG Antibody (Biotin)
20-abx400030
  • EUR 189.00
  • EUR 112.00
  • EUR 272.00
  • 100 ug
  • 10 ug
  • 1 mg

Goat Anti-Mouse IgG Antibody (FITC)
20-abx400031
  • EUR 189.00
  • EUR 112.00
  • EUR 272.00
  • 100 ug
  • 10 ug
  • 1 mg

Goat anti-Mouse IgG Antibody (BGAL)
abx401031-1ml 1 ml
EUR 370

Goat anti-Mouse IgG Antibody (RPE)
abx401034-05mg 0.5 mg
EUR 537

Goat anti-Mouse IgG Fab Antibody
abx401416-1ml 1 ml
EUR 453

Goat anti-Mouse IgG Antibody (RPE)
abx401556-1ml 1 ml
EUR 606

Mouse Anti-Goat IgG Antibody [1G12H5]
PM-6279 0.05 mg
EUR 191
Description: Mouse Anti-Goat IgG Antibody [1G12H5]

Goat Anti-Mouse IgG/HRP
E3GAM001 200ul
EUR 408

Goat Anti Mouse IgG -Biotin
E61I00502 1mg
EUR 499

Goat Anti Mouse IgG-HRP
E61I00503 1mg
EUR 499

Goat Anti Mouse IgG-FITC
E61I00504 1mg
EUR 611

Goat Anti-mouse IgG-ALP
STJ15100031 1 ml
EUR 350
Description: This ALP-conjugate enables detection of mouse IgG in enzyme immunoassays such as indirect ELISA and Western blot.

488 Goat-anti-Mouse IgG
GT26000 1 mg
EUR 375

546 Goat-anti-Mouse IgG
GT26003 1 mg
EUR 375

642 Goat-anti-Mouse IgG
GT26005 1 mg
EUR 375

Goat Anti-Mouse IgG (Fc)
GAMG80Fc-0100 100ml
EUR 404.3

Goat Anti-Mouse IgG (Fc)
GAMG80Fc-0500 500ml
EUR 707.2

Goat Anti-Mouse IgG -HRP
LF-SA8001 0.5 ml
EUR 131
Description: Goat polyclonal to mouse IgG

Goat Anti-Mouse IgG -HRP
LF-SA8001A 1.0 ml
EUR 192
Description: Goat polyclonal to mouse IgG

Goat Anti-Mouse IgG-TRITC
LF-SA8001TR 1.0 mg
EUR 287
Description: Goat polyclonal to mouse IgG

Goat anti Mouse IgG + IgM
41R-1063 1 mg
EUR 137
Description: Goat anti Mouse IgG + IgM secondary antibody

Goat anti Mouse IgG + IgM
41R-1064 1 mg
EUR 194
Description: Goat anti Mouse IgG + IgM secondary antibody

Goat anti Mouse IgG (HRP)
43C-CB1569 1 mg
EUR 198
Description: Goat anti Mouse IgG secondary antibody  (HRP)

Goat anti Mouse IgG (FITC)
43R-1359 2 mg
EUR 186
Description: Goat anti Mouse IgG secondary antibody  (FITC)

Goat anti Mouse IgG (rhodamine)
43R-1360 1 mg
EUR 138
Description: Goat anti Mouse IgG secondary antibody  (rhodamine)

Goat Anti-Mouse IgG (Fc) IgG, unlabeled
40151-UL 1 mg
EUR 213

Goat Anti-Human IgG Antibody
abx120111-5mg 5 mg
EUR 467

Rabbit Anti-Goat IgG Antibody
20-abx400048
  • EUR 189.00
  • EUR 112.00
  • EUR 272.00
  • 100 ug
  • 10 ug
  • 1 mg

Goat Anti-Rabbit IgG Antibody
20-abx400049
  • EUR 189.00
  • EUR 112.00
  • EUR 272.00
  • 100 ug
  • 10 ug
  • 1 mg

Goat anti-Rat IgG Antibody
abx401071-1mg 1 mg
EUR 328

Goat anti-Rat IgG Antibody
abx401552-05mg 0.5 mg
EUR 398

Goat Anti-toxoplasma IgG antibody（Anti-toxIgG）
QY-E140058 96T
EUR 413

Goat Anti Human IgG
E61I00201 1mg
EUR 274

Rabbit anti Goat IgG
E61I01002 1mg
EUR 343

goat Anti Rabbit IgG
E61I01301 1mg
EUR 274

Goat Anti-human IgG
STJ15100177 250 µg
EUR 283
Description: Biotinylated goat anti-human IgG enables detection of human IgG in enzyme immunoassays such as indirect ELISA.

Goat anti- human IgG
FNab09896 100µg Ask for price
Description: Antibody raised against Goat human IgG

Rabbit anti Goat IgG
20-S5801R000-VO 10 ml
EUR 133
Description: Rabbit anti Goat IgG antibody

Goat anti Human IgG
70C-CR6047GAP 1 mg
EUR 149
Description: Affinity purified Goat anti Human IgG antibody

Donkey anti Goat IgG
40-DG10 100 ml
EUR 241
Description: Donkey anti Goat IgG secondary antibody

Donkey anti Goat IgG
40-DG10S 100 ml
EUR 133
Description: Donkey anti Goat IgG secondary antibody

Goat anti Rabbit IgG
40-GR30 100 ml
EUR 241
Description: Goat anti Rabbit IgG secondary antibody

Goat anti Rabbit IgG
40-GR30S 100 ml
EUR 133
Description: Goat anti Rabbit IgG secondary antibody

Goat anti Rat IgG
40-GR38 100 ml
EUR 241
Description: Goat anti Rat IgG secondary antibody

Goat anti Cat IgG
40C-CB0215 2 mg
EUR 271
Description: Goat anti Cat IgG secondary antibody

Goat anti Cat IgG
40C-CB0229 2 mg
EUR 234
Description: Goat anti Cat IgG secondary antibody

Rabbit anti Goat IgG
40C-CB0536 1.5 mg
EUR 269
Description: Rabbit anti Goat IgG secondary antibody

Goat anti Rabbit IgG
40C-CB1157 5 mg
EUR 311
Description: Goat anti Rabbit IgG secondary antibody

Goat anti Monkey IgG
40R-IG002 1 mg
EUR 275
Description: Goat anti Monkey IgG secondary antibody

Goat anti Rabbit IgG
41-GR30 10 mg
EUR 277
Description: Goat anti Rabbit IgG secondary antibody

Goat anti Rabbit IgG
41-GR31 5 mg
EUR 162
Description: Goat anti Rabbit IgG secondary antibody

Goat anti Human IgG
41-XG56 1 mg
EUR 101
Description: Goat anti Human IgG secondary antibody

Goat anti Bovine IgG
41C-CB0136 5 mg
EUR 257
Description: Goat anti Bovine IgG secondary antibody

Rabbit anti Goat IgG
41C-CB0529 2 mg
EUR 244
Description: Rabbit anti Goat IgG secondary antibody

Goat anti Human IgG
41C-CB0957 5 mg
EUR 346
Description: Goat anti Human IgG secondary antibody

Goat anti Human IgG
41C-CB0972 2 mg
EUR 264
Description: Goat anti Human IgG secondary antibody

Goat anti Rabbit IgG
41C-CB1143 2 mg
EUR 278
Description: Goat anti Rabbit IgG secondary antibody

Goat anti Rabbit IgG
41C-CB1150 10 mg
EUR 388
Description: Goat anti Rabbit IgG secondary antibody

Goat anti Monkey IgG
41C-CB1605 1 mg
EUR 275
Description: Goat anti Monkey IgG secondary antibody

Goat anti Human IgG
41R-1026 2 mg
EUR 137
Description: Goat anti Human IgG secondary antibody

Goat anti Human IgG
41R-1027 2 mg
EUR 186
Description: Goat anti Human IgG secondary antibody

Goat anti Human IgG
41R-1028 1 mg
EUR 182
Description: Goat anti Human IgG secondary antibody

Goat anti Human IgG
41R-1029 2 mg
EUR 186
Description: Goat anti Human IgG secondary antibody

Goat anti Human IgG
41R-1030 1 mg
EUR 138
Description: Goat anti Human IgG secondary antibody

Goat anti Human IgG
41R-1031 1 mg
EUR 186
Description: Goat anti Human IgG secondary antibody

Goat anti Human IgG
41R-1032 1 mg
EUR 224
Description: Goat anti Human IgG secondary antibody

Goat anti Human IgG
41R-1033 1 mg
EUR 246
Description: Goat anti Human IgG secondary antibody

Goat anti Human IgG
41R-1034 1 mg
EUR 186
Description: Goat anti Human IgG secondary antibody

Goat anti Rabbit IgG
41R-1079 2 mg
EUR 149
Description: Goat anti Rabbit IgG secondary antibody

Donkey anti Goat IgG
41R-ID001 1 mg
EUR 229
Description: Donkey anti Goat IgG secondary antibody

Goat anti-Mouse IgG (H&L) Antibody
E61C00401 100μg/100μl
EUR 343

Goat Anti Mouse Igg (Fc) Polyclonal Antibody
CPBT-68074GM 1 mg
EUR 663

Goat Anti-Mouse IgG (H&L) Antibody
20-abx134841
  • EUR 230.00
  • EUR 286.00
  • 100 ul
  • 500 ul

Goat Anti-Mouse IgG (H+L) Antibody
abx019221-1mg 1 mg
EUR 342

Goat Anti-Mouse IgG (Fc) Antibody (Biotin)
abx023401-2ml 2 ml
EUR 578

Goat Anti-Mouse IgG (Fc) Antibody (FITC)
abx023403-2mg 2 mg
EUR 537

Goat Anti-Mouse IgG (Fc) Antibody (ALP)
abx023404-1ml 1 ml
EUR 599

Goat Anti-Mouse IgG (Fc) Antibody (HRP)
abx023406-2ml 2 ml
EUR 599

In contrast, the Animal Science Laboratory Teaching Methods course remained consistent in format through the transition to online because students were still able to participate in discussion-based activities via Zoom meetings each week due to the small class size, which helped to maintain student engagement. However, the final teaching experience was modified to an alternative assignment. The alternate assignment included self-reflection and course evaluation that will help to improve both the Farm Animal Production Systems laboratory and the Animal Science Teaching Methods course in the future. Although COVID-19 has been a challenge that disrupted traditional courses, it has provided opportunities for a traditionally hands-on discipline, such as animal science, to more effectively engage students via an online platform.

Initiation of hepatitis C treatment in two rural Rwandan districts: a mobile clinic approach

by
Initiation of hepatitis C treatment in two rural Rwandan districts: a mobile clinic approach
To eradicate hepatitis C, Rwanda is conducting nationwide mass screenings and offering to folks with continual hepatitis C free entry to Direct Acting Antivirals (DAAs). Until 2020, prescribers educated and licensed to provoke DAA treatment have been based mostly at district hospitals, and entry to DAAs stays costly and geographically troublesome for rural sufferers. We carried out a mobile clinic to supply DAA treatment initiation at primary-level well being services amongst folks with continual hepatitis C recognized via mass screening campaigns in rural Kirehe and Kayonza districts.
The mobile clinic workforce was composed of one clinician licensed to handle hepatitis, one lab technician, and one driver. Eligible sufferers acquired same-day medical consultations, counselling, laboratory exams and DAA initiation. Using medical databases, registers, and program data, we in contrast the quantity of sufferers who initiated DAA treatment earlier than and in the course of the mobile clinic marketing campaign. We assessed linkage to care in the course of the mobile medical marketing campaign and assessed predictors of linkage to care. We additionally estimated the associated fee per affected person of offering mobile providers and the discount in out-of-pocket prices related to accessing DAA treatment via the mobile clinic moderately than the usual of care.
Prior to the mobile clinic, solely 408 sufferers in Kirehe and Kayonza had been initiated on DAAs over a 25-month interval. Between November 2019 and January 2020, out of 661 eligible sufferers with hepatitis C, 429 (64.9%) have been linked to care via the mobile clinic. Having a phone quantity and full handle recorded at screening have been strongly related to linkage to care. The value per affected person of the mobile clinic program was 29.36 USD, excluding government-provided DAAs.
Providing sufferers with same-day laboratory exams and medical session at primary-level well being services lowered out-of-pocket bills by 9.88 USD. The mobile clinic was a possible technique for offering speedy treatment initiation amongst folks chronically contaminated by hepatitis C, recognized via a mass screening marketing campaign. Compared to the usual of care, mobile clinics reached extra sufferers in a a lot shorter time. This low-cost technique additionally lowered out-of-pocket expenditures amongst sufferers. However, long-term, sustainable care would require decentralization to the first well being-centre stage.

Seasonal Diversity of Lactic Acid Bacteria in Artisanal Yoghurt and Their Antibiotic Susceptibility Pattern

The microbiological high quality of artisanal yoghurt marketed in some areas of Cameroon was evaluated in the course of the dry and wet seasons alongside three industrial manufacturers and the susceptibility of isolates to some typical antibiotics. A complete of ninety-six (96) samples have been collected, and the microbiological high quality was based mostly on the entire depend of lactic acid micro organism (lactobacilli and cocci) in addition to the identification of species current utilizing identification kits. The susceptibility of isolates was decided utilizing the microdilution methodology. The lactobacillus counts of domestically made yoghurts throughout each seasons have been decrease than these of the industrial samples.

However, there was a common discount of viable depend of lactobacilli throughout the samples in the course of the wet season when in comparison with the dry season whereas a common improve in the entire coccus depend was noticed in the course of the wet season besides samples from Bamenda which as a substitute decreased. Five (5) Lactobacillus species belonging to 1 genera have been recognized from 29 lactobacillus isolates. Lactobacillus bulgaricus was the very best (64.28%), current in 71.42%, 50.00%, 33.33%, and 33.33% (dry season) in comparison with 85.71%, 100%, 33.33%, and 25.00% (wet season) from Bamenda, Dschang, Bafoussam, and industrial, respectively. More so, 14 cocci,

Three coccobacilli, and 1 rod species belonging to five, 3, and 1 genera have been recognized, from 74 cocci, 12 coccobacilli, and three rod isolates, respectively, with Streptococcus thermophilus being the very best (35.55%). However, 93.33% of the lactobacillus isolates have been very delicate to the antibiotics used, whereas solely 20% of cocci have been delicate. This outcome means that the paucity of the suitable lactic acid micro organism (LAB) and presence of pathogenic LAB attributable to the absence of high quality management and ignorance may hinder its well being advantages and safety supplied to customers with a resultant publicity to excessive danger of meals borne an infection and intoxication coupled to the resistant strains.

Utilization administration of laboratory testing is a development growing in relevance because the well beingcare panorama continues to evolve towards value-based care, and lots of pediatric and grownup laboratories are growing methods for utilization administration. The Pediatric Laboratory Guidance Service (PLUGS) began an annual convention devoted to the vital subjects and challenges associated to lab utilization. This 12 months, the 2-day PLUGS Summit boasted over 10 hours of persevering with medical training and a number of other networking occasions to convey collectively leaders in the sector of lab utilization. The theme of the 2016 assembly targeted on bringing collectively medical labs, reference labs, and insurance coverage firms to extend the worth of laboratory testing, in the context of the US well being financial system.

Initiation of hepatitis C treatment in two rural Rwandan districts: a mobile clinic approach

Linking clinotypes to phenotypes and genotypes from laboratory take a look at outcomes in complete bodily exams

In this work, we aimed to reveal find out how to make the most of the lab take a look at outcomes and different medical data to help precision medication analysis and medical selections on complicated illnesses, with the help of digital medical report services. We outlined “clinotypes” as medical data that might be noticed and measured objectively utilizing biomedical devices. From well-known ‘omic’ drawback definitions, we outlined issues utilizing clinotype data, together with stratifying patients-identifying sub cohorts for future research
mining important associations between clinotypes and particular phenotypes-diseases, and discovering potential linkages between clinotype and genomic data. We solved these issues by integrating public omic databases and making use of superior machine studying and visible analytic methods on two-year well being examination data from a giant inhabitants of well beingy southern Chinese people (dimension n = 91,354). When growing the answer, we rigorously addressed the lacking data, imbalance and non-uniformed knowledge annotation points.

Anti-human CD19 Monoclonal Antibody FITC Conjugated, Flow Validated
FC00154-FITC 25 Tests, 100 Tests, 200 Tests
EUR 102
Description: Mouse Monoclonal human CD19 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD38 Monoclonal Antibody FITC Conjugated, Flow Validated
FC00193-FITC 25 Tests, 100 Tests, 200 Tests
EUR 137
Description: Mouse Monoclonal human CD38 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD25 Monoclonal Antibody FITC Conjugated, Flow Validated
FC00214-FITC 25 Tests, 100 Tests, 200 Tests
EUR 108
Description: Mouse Monoclonal human CD25 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD4 Monoclonal Antibody FITC Conjugated, Flow Validated
FC00344-FITC 25 Tests, 100 Tests, 200 Tests
EUR 96
Description: Mouse Monoclonal human CD4 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD5 Monoclonal Antibody FITC Conjugated, Flow Validated
FC00480-FITC 25 Tests, 100 Tests, 200 Tests
EUR 137
Description: Mouse Monoclonal human CD5 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD45 Monoclonal Antibody FITC Conjugated, Flow Validated
FC00555-FITC 25 Tests, 100 Tests, 200 Tests
EUR 114
Description: Mouse Monoclonal human CD45 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD2 Monoclonal Antibody FITC Conjugated, Flow Validated
FC00570-FITC 25 Tests, 100 Tests, 200 Tests
EUR 137
Description: Mouse Monoclonal human CD2 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD71 Monoclonal Antibody FITC Conjugated, Flow Validated
FC00591-FITC 25 Tests, 100 Tests, 200 Tests
EUR 137
Description: Mouse Monoclonal human CD71 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD62L Monoclonal Antibody FITC Conjugated, Flow Validated
FC00652-FITC 25 Tests, 100 Tests, 200 Tests
EUR 137
Description: Mouse Monoclonal human CD62L Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD59 Monoclonal Antibody FITC Conjugated, Flow Validated
FC00914-FITC 25 Tests, 100 Tests, 200 Tests
EUR 137
Description: Mouse Monoclonal human CD59 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-Human CD81 Monoclonal Antibody FITC Conjugated, Flow Validated
FC01281-FITC 25 Tests, 100 Tests, 200 Tests
EUR 137
Description: Mouse Monoclonal Human CD81 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD117 Monoclonal Antibody FITC Conjugated, Flow Validated
FC01335-FITC 25 Tests, 100 Tests, 200 Tests
EUR 137
Description: Mouse Monoclonal human CD117 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD16 Monoclonal Antibody FITC Conjugated, Flow Validated
FC01408-FITC 25 Tests, 100 Tests, 200 Tests
EUR 137
Description: Mouse Monoclonal human CD16 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD32 Monoclonal Antibody FITC Conjugated, Flow Validated
FC01450-FITC 25 Tests, 100 Tests, 200 Tests
EUR 120
Description: Mouse Monoclonal human CD32 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-Human CD31 Monoclonal Antibody FITC Conjugated, Flow Validated
FC01513-FITC 25 Tests, 100 Tests, 200 Tests
EUR 130
Description: Mouse Monoclonal Human CD31 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD90 Monoclonal Antibody FITC Conjugated, Flow Validated
FC01818-FITC 25 Tests, 100 Tests, 200 Tests
EUR 153
Description: Mouse Monoclonal human CD90 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD7 Monoclonal Antibody FITC Conjugated, Flow Validated
FC01974-FITC 25 Tests, 100 Tests, 200 Tests
EUR 137
Description: Mouse Monoclonal human CD7 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD235a Monoclonal Antibody FITC Conjugated, Flow Validated
FC02184-FITC 25ug, 100ug
EUR 140
Description: Mouse Monoclonal human CD235a Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD8 Monoclonal Antibody FITC Conjugated, Flow Validated
FC02236-FITC 25 Tests, 100 Tests, 200 Tests
EUR 96
Description: Mouse Monoclonal human CD8 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD13 Monoclonal Antibody FITC Conjugated, Flow Validated
FC02591-FITC 25 Tests, 100 Tests, 200 Tests
EUR 137
Description: Mouse Monoclonal human CD13 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD3 Monoclonal Antibody FITC Conjugated, Flow Validated
FC02675-FITC 25 Tests, 100 Tests, 200 Tests
EUR 101
Description: Mouse Monoclonal human CD3 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD20 Monoclonal Antibody FITC Conjugated, Flow Validated
FC03780-FITC 25 Tests, 100 Tests, 200 Tests
EUR 137
Description: Mouse Monoclonal human CD20 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-Human CD161 Monoclonal Antibody FITC Conjugated, Flow Validated
FC03917-FITC 25 tests, 100 tests
EUR 160
Description: Mouse Monoclonal Human CD161 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD10 Monoclonal Antibody FITC Conjugated, Flow Validated
FC04065-FITC 25 Tests, 100 Tests, 200 Tests
EUR 125
Description: Mouse Monoclonal human CD10 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-Human CD3 Monoclonal Antibody FITC Conjugated, Flow Validated
FC04405-FITC 25 tests, 100 tests
EUR 96
Description: Mouse Monoclonal Human CD3 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-Human CD11a Monoclonal Antibody FITC Conjugated, Flow Validated
FC04466-FITC 25 Tests, 100 Tests, 200 Tests
EUR 137
Description: Mouse Monoclonal Human CD11a Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD15 Monoclonal Antibody FITC Conjugated, Flow Validated
FC04535-FITC 25 Tests, 100 Tests, 200 Tests
EUR 137
Description: Mouse Monoclonal human CD15 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-Human CD66b Monoclonal Antibody FITC Conjugated, Flow Validated
FC05978-FITC 25 tests, 100 tests
EUR 137
Description: Mouse Monoclonal Human CD66b Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD57 Monoclonal Antibody FITC Conjugated, Flow Validated
FC09548-FITC 25 Tests, 100 Tests, 200 Tests
EUR 140
Description: Mouse Monoclonal human CD57 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human HLA-DR Monoclonal Antibody FITC Conjugated, Flow Validated
FC00568-FITC 25 Tests, 100 Tests, 200 Tests
EUR 137
Description: Mouse Monoclonal human HLA-DR Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD55/Daf Monoclonal Antibody FITC Conjugated, Flow Validated
FC00910-FITC 25 Tests, 100 Tests, 200 Tests
EUR 137
Description: Mouse Monoclonal human CD55/Daf Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-Mouse TCR beta Monoclonal Antibody FITC Conjugated, Flow Validated
FC09166-FITC 25 ug, 100ug, 500ug
EUR 91
Description: Hamster Monoclonal Mouse TCR beta Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Mouse.

Anti-Human HLA-ABC Monoclonal Antibody FITC Conjugated, Flow Validated
FC20056-FITC 25 Tests , 100 Tests , 200 Tests
EUR 137
Description: Mouse Monoclonal Human HLA-ABC Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-Human CD54 (ICAM-1) Monoclonal Antibody FITC Conjugated, Flow Validated
FC00171-FITC 25 tests, 100 tests
EUR 149
Description: Mouse Monoclonal Human CD54 (ICAM-1) Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD33/Siglec 3 Monoclonal Antibody FITC Conjugated, Flow Validated
FC01508-FITC 25 Tests, 100 Tests, 200 Tests
EUR 137
Description: Mouse Monoclonal human CD33/Siglec 3 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD22/Siglec 2 Monoclonal Antibody FITC Conjugated, Flow Validated
FC01572-FITC 25 Tests, 100 Tests, 200 Tests
EUR 137
Description: Mouse Monoclonal human CD22/Siglec 2 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-Human CD14 Monoclonal Antibody FITC Conjugated, Flow Validated
FC00137-FITC-1 25 Tests, 100 Tests, 200 Tests
EUR 95
Description: Mouse Monoclonal Human CD14 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-Mouse CD19 Monoclonal Antibody FITC Conjugated, Flow Validated
FC00154-1-FITC 25ug, 100ug, 500ug
EUR 96
Description: Rat Monoclonal Mouse CD19 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Mouse.

Anti-Human CD54 Monoclonal Antibody FITC Conjugated, Flow Validated
FC00171-FITC-1 25 Tests, 100 Tests, 200 Tests
EUR 130
Description: Mouse Monoclonal Human CD54 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-Mouse CD4 Monoclonal Antibody FITC Conjugated, Flow Validated
FC00344-3-FITC 25ug, 100ug, 500ug
EUR 85
Description: Rat Monoclonal Mouse CD4 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Mouse.

Anti-Mouse CD45.2 Monoclonal Antibody FITC Conjugated, Flow Validated
FC00555-8-FITC 25ug, 100ug, 500ug
EUR 96
Description: Mouse Monoclonal Mouse CD45.2 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Mouse.

Anti-Human CD45RO Monoclonal Antibody FITC Conjugated, Flow Validated
FC00555-FITC-1 25 Tests, 100 Tests, 200 Tests
EUR 137
Description: Mouse Monoclonal Human CD45RO Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-Human CD3 Monoclonal Antibody FITC Conjugated, Flow Validated
FC02675-FITC-1 25 Tests, 100 Tests, 200 Tests
EUR 73
Description: Mouse Monoclonal Human CD3 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-Mouse CD3e Monoclonal Antibody FITC Conjugated, Flow Validated
FC04405-3-FITC 25ug, 100ug, 500ug
EUR 79
Description: Hamster Monoclonal Mouse CD3e Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Mouse.

Anti-Human CD3 Monoclonal Antibody FITC Conjugated, Flow Validated
FC04405-4-FITC 25 tests, 100 tests, 500 tests
EUR 96
Description: Mouse Monoclonal Human CD3 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Mouse anti-human CD7 Monoclonal Antibody FITC Conjugated, Flow Validated
FC01974-1-FITC 25 Tests, 100 Tests, 200 Tests
EUR 137
Description: Mouse Monoclonal Mouse human CD7 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Concanavalin A Lectin (ConA)-FITC conjugate
CONA15-FITC 0.5 ml
EUR 286

Rabbit Anti-Salmonella IgG-FITC conjugate
SLM11-FITC 0.5 ml
EUR 347

Sambucus nigra Lectin (SNA)-FITC conjugate
SNA15-FITC 0.5 ml
EUR 286

Lens culinaris Lectin (LCA)-FITC conjugate
LCA15-FITC 0.5 ml
EUR 286

Aleuria Aurantia Lectin (Aal)-FITC conjugate
AAL15-FITC 0.5 ml
EUR 225

Monoclonal Anti-Rat IgG1-FITC Conjugate
50126-FITC 0.5 ml
EUR 286

Recombinant (E.Coli) purified Protein G-FITC Conjugate
PRTG15-FITC 1 ml
EUR 202

Wheat germ agglutinin Lectin (WGA)-FITC conjugate
WGA15-FITC 0.5 ml
EUR 286

Goat Anti-Mouse albumin IgG-FITC Conjugate
ALB11-FITC 100 ug
EUR 347

Goat Anti-Human albumin IgG-FITC Conjugate
ALBH13-FITC 100 ug
EUR 347

Goat Anti-Mouse IgG (Fc) IgG-FITC Conjugate
40151-FITC 1 ml
EUR 225

Ricinus communis (castor bean) Agglutinin (RCA120)-FITC conjugate
RCA15-FITC 0.5 ml
EUR 225

Rabbit Anti-Luciferase (Photobacterium fischerii) IgG-FITC Conjugate
LUCF12-FITC 500 ul
EUR 384

Monoclonal Anti-Adenovirus (many isotypes) IgG-FITC conjugate
ADV12-FITC 100 ul
EUR 469

Mouse Monoclonal Anti-Human IgG1 (Fc-region)-FITC conjugate
10121-FITC 0.5 ml
EUR 225

Mouse Monoclonal Anti-Human IgG2 (Fc-region)-FITC conjugate
10122-FITC 0.5 ml
EUR 225

Mouse Monoclonal Anti-Human IgG3 (Hinge-region)-FITC conjugate
10123-FITC 0.5 ml
EUR 286

Mouse Monoclonal Anti-Human IgG4 (Fc-region)-FITC conjugate
10124-FITC 0.5 ml
EUR 286

Rabbit anti-Beta-Galactosidase (E. Coli) IgG-FITC conjugate
BGAL12-FITC 100 ul
EUR 347

Goat Anti-Poliomyelitis Virus 1-3 IgG-FITC Conjugate
POLV13-FITC 0.5 ml
EUR 408

Goat Anti-Rubella virus (HPV77 strain) IgG-FITC conjugate
RUBL11-FITC 1 ml
EUR 347

Goat Anti-Adenovirus type 2, hexon IgG-FITC conjugate
ADV11-FITC 0.5 ml
EUR 408

FITC Conjugated Avidin
BA1125-0.5 0.5ml
EUR 187

FITC Conjugated Avidin
BA1125-1 1ml
EUR 334

Casein, FITC-conjugated
13440 5 mg
EUR 219

Goat Anti-Human Respiratory Syncytial Virus (RSV) IgG-FITC conjugate
RSV12-FITC 0.5 ml
EUR 469

Goat Anti-Hemeagglutinin fusion epitope (HA-tag) IgG-FITC conjugate
HA12-FITC 100 ug
EUR 347

Goat Anti-Poly-His (6xhis) (His-tag) IgG-FITC conjugate
HISP16-FITC 100 ul
EUR 347

Goat Anti-Glutathione Transferase (GST, S. japonicum) IgG-FITC Conjugate
GST13-FITC 100 ul
EUR 347

Rabbit Anti-Bovine Serum Albumin (BSA) protein IgG-FITC Conjugate
ALBB14-FITC 0.5 ml
EUR 347

Goat Anti-human C-Reactive Protein (CRP)-FITC Conjugate, aff pure
CRP11-FITC 100 ug
EUR 408

Rabbit Anti-Vaccinia virus (VACV/VV/small pox) IgG-FITC conjugate
VACV11-FITC 0.5 ml
EUR 408

Monoclonal Anti-Human Beta Actin peptide (non-muscle) IgG-FITC Conjugate
ACTB12-FITC 100 ul
EUR 408

Mouse Monoclonal Anti-Actin (Pan, alpha, beta, gamma) IgG-FITC conjugate
ACTB24-FITC 100 ul
EUR 408

Goat Anti-Green Fluorescent Proteins (GFP, A. victoria) protein IgG-FITC conjugate
GFP11-FITC 100 ug
EUR 347

Monoclonal Anti-Green Fluorescent Proteins (GFP, A. victoria) protein IgG-FITC conjugate
GFP12-FITC 0.5 ml
EUR 408

F(ab')2 fragment, Goat Anti-Mouse IgG (Fab)2 IgG-FITC Conjugate
40155-FITC 0.5 ml
EUR 263

Mouse mono Anti-human CRP (C-Reactive Protein) (clone 1) IgG-FITC conjugate
CRP13-FITC 100 ug
EUR 347

Mouse monoclonal Anti-Rabies Virus IgG-FITC conjugate (DFA II mix of 2 clones)
RBV15-FITC 1 ml
EUR 286

FITC Conjugated Protein A
BA1120-0.5 0.5ml
EUR 182

FITC Conjugated Protein A
BA1120-1 1ml
EUR 304

FITC Conjugated Protein G
BA1121-0.5 0.5ml
EUR 182

FITC Conjugated Protein G
BA1121-1 1ml
EUR 304

UQCRQ Antibody, FITC conjugated
1-CSB-PA03855C0Rb
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against UQCRQ. Recognizes UQCRQ from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

KAT7 Antibody, FITC conjugated
1-CSB-PA03865C0Rb
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against KAT7. Recognizes KAT7 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

TUBB3 Antibody, FITC conjugated
1-CSB-PA03874C0Rb
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against TUBB3. Recognizes TUBB3 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

TUBB3 Antibody, FITC conjugated
1-CSB-PA03879C0Rb
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against TUBB3. Recognizes TUBB3 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

TMEM109 Antibody, FITC conjugated
1-CSB-PA03899C0Rb
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against TMEM109. Recognizes TMEM109 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

DNAJB1 Antibody, FITC conjugated
1-CSB-PA03934C0Rb
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against DNAJB1. Recognizes DNAJB1 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

virD2 Antibody, FITC conjugated
1-CSB-PA03944C0Rb
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against virD2. Recognizes virD2 from Agrobacterium tumefaciens. This antibody is FITC conjugated. Tested in the following application: ELISA
We organized the methods and options to handle the issues and points above into CPA framework (Clinotype Prediction and Association-finding). At the info preprocessing step, we dealt with the lacking worth problem with predicted accuracy of 0.760. We curated 12,635 clinotype-gene associations. We discovered 147 Associations between 147 continual diseases-phenotype and clinotypes, which improved the illness predictive efficiency to AUC (common) of 0.967. We mined 182 important clinotype-clinotype associations amongst 69 clinotypes.

An alternative food source for metabolism and longevity studies in Caenorhabditis elegans

by
An alternative food source for metabolism and longevity studies in Caenorhabditis elegans

Caenorhabditis elegans is an instrumental analysis mannequin used to advance our data in areas together with growth, metabolism, and getting old. However, analysis on metabolism and/or different measures of well being/getting old are confounded by the nematode’s food source in the lab, reside E. coli micro organism. Commonly used therapies, together with ultraviolet irradiation and antibiotics, are profitable in stopping bacterial replication, however the micro organism can stay metabolically energetic. The goal of this examine is to develop a metabolically inactive food source for the worms that may enable us to attenuate the confounding results of bacterial metabolism on worm metabolism and getting old.

Our technique is to make use of a paraformaldehyde (PFA) handled E. coli food source and to find out its results on worm well being, metabolism and longevity. We initially decide the bottom potential concentrations of PFA essential to quickly and reproducibly kill micro organism. We then measure numerous points of worm conduct, well beingspan and longevity, together with progress price, food attraction, brood measurement, lifespan and metabolic assessments, comparable to oxygen consumption and metabolomics. Our ensuing knowledge present that worms eat and develop effectively on these micro organism and assist the usage of 0.5% PFA-killed micro organism as a nematode food source for metabolic, drug, and longevity experiments.

Primary goal 1. To assess the consequences of offering grownup sufferers with entry to digital well being information (EHRs) alone or with extra functionalities on a variety of affected person, patient-provider, and well being useful resource consumption outcomes, together with affected person data and understanding, affected person empowerment, affected person adherence, affected person satisfaction with care, adversarial occasions, well being-related high quality of life, well being-related outcomes, psychosocial well being outcomes, well being useful resource consumption, and patient-provider communication. Secondary goal 1. To assess whether or not results of offering grownup sufferers with EHR entry alone versus EHR entry with extra functionalities differ amongst affected person teams in line with age, academic degree, or completely different standing of illness (power or acute).

An alternative food source for metabolism and longevity studies in Caenorhabditis elegans

Adult affected person entry to digital well being information

We included 10 studies with 78 to 4500 members and follow-up from three to 24 months. Nine studies assessed the consequences of EHR with extra functionalities, every addressing a subset of outcomes sought by this assessment. Five studies targeted on sufferers with diabetes mellitus, 4 on sufferers with particular ailments, and one on all sufferers. All studies in contrast EHR entry alone or with extra functionalities plus normal care versus normal care solely. No studies assessing the consequences of EHR entry alone versus EHR entry with extra functionalities had been recognized.

Interventions required a wide range of knowledge throughout the EHR, comparable to affected person historical past, drawback record, treatment, allergy symptoms, and lab outcomes. In addition to EHR entry, eight studies allowed sufferers to share self-documented knowledge, seven provided individualised illness administration features, seven provided academic disease-related info, six supported safe communication, and one provided preventive reminders. Only two studies had been at low or unclear threat of bias throughout domains. Meta-analysis couldn’t be carried out, as members, interventions, and outcomes had been too heterogeneous, and most studies introduced outcomes primarily based on completely different adjustment strategies or variables.

The high quality of proof was rated as low or very low throughout outcomes. Overall variations between intervention and management teams, if any, had been small. The relevance of any small results stays unclear for most outcomes as a result of in most instances, trial authors didn’t outline a minimal clinically essential distinction. Overall, outcomes recommend that the consequences of EHR entry alone and with extra functionalities are principally unsure compared with normal care. Patient data and understanding: very low-quality proof is offered from one examine, so we’re unsure about results of the intervention on affected person data about diabetes and blood glucose testing.

Patient empowerment: low-quality proof from three studies means that the intervention might have little or no impact on affected person empowerment measures. Patient adherence: low-quality proof from two studies means that the intervention might barely enhance adherence to the method of monitoring threat components and preventive providers. Effects on treatment adherence are conflicting in two studies; this will likely or might not enhance to a clinically related diploma. Patient satisfaction with care: low-quality proof from three studies means that the intervention might have little or no impact on affected person satisfaction, with conflicting outcomes.

Anti-RXR-γ Antibody
A04250-1 1ml
EUR 464
Description: Rabbit Polyclonal RXR-γ Antibody. Validated in IHC and tested in Human, Mouse, Rat.

Recombinant Rat MIP-1 Alpha (CCL3) Protein
PROTP50229-1 20ug
EUR 317
Description: Both MIP-1α and MIP-1β are structurally and functionally related CC chemokines. They participate in the host response to invading bacterial, viral, parasite and fungal pathogens by regulating the trafficking and activation state of selected subgroups of inflammatory cells e.g. macrophages, lymphocytes and NK cells. While both MIP-1α and MIP-1β exert similar effects on monocytes their effect on lymphocytes differ; with MIP-1α selectively attracting CD8+ lymphocytes and MIP-1β selectively attracting CD4+ lymphocytes. Additionally, MIP-1α and MIP-1β have also been shown to be potent chemoattractants for B cells, eosinophils and dendritic cells. Both human and murine MIP-1α and MIP-1β are active on human and murine hematopoietic cells. Recombinant rat MIP-1α is a 7.8 kDa protein containing 69 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines.

Recombinant Rat MIP-1 Beta (CCL4) Protein
PROTP50230-1 20ug
EUR 317
Description: Both MIP-1α and MIP-1β are structurally and functionally related CC chemokines. They participate in the host response to invading bacterial, viral, parasite and fungal pathogens by regulating the trafficking and activation state of selected subgroups of inflammatory cells e.g. macrophages, lymphocytes and NK cells. While both MIP-1α and MIP-1β exert similar effects on monocytes their effect on lymphocytes differ; with MIP-1α selectively attracting CD8+ lymphocytes and MIP-1β selectively attracting CD4+ lymphocytes. Additionally, MIP-1α and MIP-1β have also been shown to be potent chemoattractants for B cells, eosinophils and dendritic cells. Both human and murine MIP-1α and MIP-1β are active on human and murine hematopoietic cells. Recombinant rat MIP-1β is a 7.8 kDa protein containing 69 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines.

Recombinant Murine MIP-1 Beta (CCL4) Protein
PROTP14097-1 10ug
EUR 317
Description: Both MIP-1α and MIP-1β are structurally and functionally related CC chemokines. They participate in the host response to invading bacterial, viral, parasite and fungal pathogens by regulating the trafficking and activation state of selected subgroups of inflammatory cells e.g. macrophages, lymphocytes and NK cells. While both MIP-1α and MIP-1β exert similar effects on monocytes their effect on lymphocytes differ; with MIP-1α selectively attracting CD8+ lymphocytes and MIP-1β selectively attracting CD4+ lymphocytes. Additionally, MIP-1α and MIP-1β have also been shown to be potent chemoattractants for B cells, eosinophils and dendritic cells. Both human and murine MIP-1α and MIP-1β are active on human and murine hematopoietic cells. Recombinant murine MIP-1β is a 7.8 kDa protein containing 69 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines.

Anti-MIP-1 alpha Antibody
A00405 100ug
EUR 432
Description: Rabbit Polyclonal MIP-1 alpha Antibody. Validated in WB and tested in Mouse.

MIP-1 Macrophage Inflammatory Protein-1 Gamma Mouse Recombinant Protein (CCL9)
PROTP51670 Regular: 20ug
EUR 317
Description: MIP-1 gamma Mouse Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 101 amino acids and having a molecular mass of 11.6 kDa. The MIP-1 gamma is purified by proprietary chromatographic techniques.

Mouse CCL9/Mip 1 Gamma PicoKine™ Fast ELISA Kit
FEK1225 96 wells
EUR 475
Description: The Fast version of Picokine ELISA kits, assay takes less than 1.5 hours. Detect Mouse Mip 1 Gamma/Ccl9 with <1pg/ml sensitivity. Format: 96-well plate with removable strips. Compatible samples: cell culture supernates, cell lysates, serum and plasma (heparin, EDTA). This is a TMB colorimetric sandwich ELISA kit with short assay time and fast experiment set up. Mip 1 Gamma/Ccl9 tissue specificity: Expressed mainly in the liver, lung, and the thymus, although some expression has been The Fast version of Picokine ELISA kits, assay takes less than 1.5 hours. Detected in a wide variety of tissues except brain.

Anti-HP1 gamma Monoclonal Antibody
M01142-1 100ug
EUR 397
Description: Rabbit Monoclonal HP1 gamma Antibody. Validated in IP, WB and tested in Human, Mouse, Rat.

Anti-gamma Catenin/JUP Antibody
PA1117-1 100ug/vial
EUR 294

Anti-IKK gamma/IKBKG Antibody
PA1551-1 100ug/vial
EUR 294

Anti-NEMO/IKK-gamma Antibody
A00874-1 100ug
EUR 455
Description: Rabbit Polyclonal NEMO/IKK-gamma Antibody. Validated in IP, WB and tested in Human.

Anti-PAK gamma Monoclonal Antibody
A01419-1 100ul
EUR 397
Description: Mouse Monoclonal Antibody for PAK gamma Antibody (PAK2) detection. Tested with WB, IHC, IF in Human, Monkey.

Anti-CEBPG/Cebp Gamma Antibody
A09205-1 100ul
EUR 397
Description: Rabbit Polyclonal CEBPG/Cebp Gamma Antibody. Validated in IHC, WB and tested in Human, Mouse, Rat.

MIP-1a Macrophage Inflammatory Protein-1 Alpha Mouse Recombinant Protein (CCL3)
PROTP10855-1 Regular: 10ug
EUR 317
Description: Macrophage Inflammatory Protein-1 alpha Mouse Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 69 amino acids and having a molecular mass of 7820 Dalton. ;The MIP-1a is purified by proprietary chromatographic techniques.

Anti-MIP antibody
STJ24556 100 µl
EUR 277
Description: Major intrinsic protein is a member of the water-transporting aquaporins as well as the original member of the MIP family of channel proteins. The function of the fiber cell membrane protein encoded by this gene is undetermined, yet this protein is speculated to play a role in intracellular communication. The MIP protein is expressed in the ocular lens and is required for correct lens function. This gene has been mapped among aquaporins AQP2, AQP5, and AQP6, in a potential gene cluster at 12q13.

anti- MIP antibody
FNab05193 100µg
EUR 548.75
Description: Antibody raised against MIP

anti- MIP-3
LSMab09791 100 ug
EUR 386

Anti-MIP antibody
PAab05193 100 ug
EUR 386

MIP-1
EF017887 96 Tests
EUR 689

MIP-1
EF013758 96 Tests
EUR 689

MIP-1
EF013759 96 Tests
EUR 689

MIP-1
EF016651 96 Tests
EUR 689

MIP-1
EF016834 96 Tests
EUR 689

MIP-1
EF017045 96 Tests
EUR 689

MIP-1
EF012725 96 Tests
EUR 689

MIP-1
EF000186 96 Tests
EUR 689

Rabbit Anti Mouse Mip-1 Alpha Polyclonal Antibody
CPBT-65209RM 0.1 mg
EUR 881

Mouse Interferon-gamma (IFN-gamma) AssayMax ELISA Kit
EMI1023-1 96 Well Plate
EUR 477

Anti-Interferon gamma Rabbit Monoclonal Antibody
M00393-1 100ug/vial
EUR 397
Description: Rabbit Monoclonal Interferon gamma Antibody. Validated in Flow Cytometry, IF, ICC, WB and tested in Human, Mouse, Rat.

Anti-Catenin gamma Rabbit Monoclonal Antibody
M01901-1 100ug/vial
EUR 397
Description: Rabbit Monoclonal Catenin gamma Antibody. Validated in IF, WB and tested in Human, Mouse, Rat.

Anti-Fibrinogen gamma chain/FGG Antibody
A00790-1 100ug/vial
EUR 334

MIP-3beta, murine recombinant protein
P1049-.1 100 µg
EUR 877
Description: Macrophage inflammatory protein-3 ? (MIP-3?) is a CC chemokine produced in the thymus, lymph nodes and activated bone marrow stromal cells. MIP-3? signals through the chemokine receptor CCR-7/EBI-1/BLR-2. MIP-3? is a chemoattractant for T and B lymphocytes, and myeloid progenitor cells.

MIP-3beta, murine recombinant protein
P1049-1 1 mg
EUR 5548
Description: Macrophage inflammatory protein-3 ? (MIP-3?) is a CC chemokine produced in the thymus, lymph nodes and activated bone marrow stromal cells. MIP-3? signals through the chemokine receptor CCR-7/EBI-1/BLR-2. MIP-3? is a chemoattractant for T and B lymphocytes, and myeloid progenitor cells.

Anti-Interferon gamma Biotinylated Antibody
A00393-1-Biotin 50ug/vial
EUR 294

Anti-strogen Related Receptor gamma/ESRRG Antibody
A01470-1 100ug/vial
EUR 334

Anti-MIP-5 Antibody
A05563 100ul
EUR 397
Description: Rabbit Polyclonal Antibody for MIP-5 Antibody (CCL15) detection.tested for IHC in Human.

Anti-MIP-1b Antibody
A16621 100ul
EUR 397
Description: Rabbit Polyclonal Antibody for MIP-1b Antibody (CCL4L1) detection. Tested with WB in Human.

Anti-MIP- beta antibody
STJ96572 200 µl
EUR 197
Description: Rabbit polyclonal to MIP-1beta.

Anti-MIP-1b antibody
STJ97347 200 µl
EUR 197
Description: Rabbit polyclonal to MIP-1b.

Anti-MIP- alpha antibody
STJ98775 200 µl
EUR 197
Description: Rabbit polyclonal to MIP-3alpha.

Anti-MIP-5 antibody
STJ98780 200 µl
EUR 197
Description: Rabbit polyclonal to MIP-5.

Anti-MIP- alpha antibody
STJ94130 200 µl
EUR 197
Description: Rabbit polyclonal to MIP-1alpha.

Anti-MIP- beta antibody
STJ94131 200 µl
EUR 197
Description: Rabbit polyclonal to MIP-3beta.

Anti-MIP-T3 antibody
STJ94133 200 µl
EUR 197
Description: Rabbit polyclonal to MIP-T3.

anti- MIP-3α antibody
FNab09791 100µg
EUR 548.75
Description: Antibody raised against MIP-3α

Recombinant Human MIP-3 (CCL23) Protein
PROTP55773-1 20ug
EUR 317
Description: MIP-3 is a CC chemokine that signals through the CCR1 receptor. MIP-3 chemoattracts monocytes, resting T-lymphocytes and neutrophils, but does not chemoattract activated lymphocytes. Additionally, MIP-3 has been shown to inhibit colony formation of bone marrow myeloid immature progenitors. Recombinant human MIP-3 is an 11.3 kDa protein containing 99 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines.

Recombinant Murine MIP-2 (CXCL2) Protein
PROTP10889-1 20ug
EUR 317
Description: All three isoforms of GRO are CXC chemokines that can signal through the CXCR1 or CXCR2 receptors. The GRO proteins chemoattract and activate neutrophils and basophils. Recombinant murine MIP-2 is a 7.8 kDa protein consisting of 73 amino acids including the 'ELR' motif common to the CXC chemokine family that bind to CXCR1 or CXCR2.

Polyclonal Goat anti-GST μ-form
GST-ANTI-2 50 uL
EUR 280

Polyclonal Goat anti-GST p-form
GST-ANTI-3 50 uL
EUR 280

anti-AMPK gamma 1
YF-PA13985 100 ug
EUR 403
Description: Rabbit polyclonal to AMPK gamma 1

anti-Laminin gamma 1
YF-PA24068 50 ul
EUR 334
Description: Mouse polyclonal to Laminin gamma 1

Recombinant Human MIP-3 Beta (CCL19) Protein
PROTQ99731-1 20ug
EUR 317
Description: MIP-3β is a CC chemokine that is expressed in the thymus, lymph nodes and in activated bone marrow stromal cells and signals through the CCR7 receptor. MIP-3β is a chemoattractant for T and B lymphocytes and myeloid progenitor cells. Human MIP-3β is active on murine cells. Recombinant human MIP-3β is an 8.8 kDa protein containing 77 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines.

Recombinant Murine MIP-3 Alpha (CCL20) Protein
PROTO89093-1 20ug
EUR 317
Description: MIP-3α is a CC chemokine that is expressed in the liver, lymph nodes, appendix, PBL and lung and signals through the CCR6 receptor. MIP-3α is chemotactic towards lymphocytes and dendritic cells. Additionally, it promotes the adhesion of memory CD4+ T cells and inhibits colony formation of bone marrow myeloid immature progenitors. Recombinant murine MIP-3α is a 7.9 kDa protein containing 70 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines.

Rabbit Anti Mouse Mip-2 Polyclonal Antibody
CPBT-65215RM 0.1 mg
EUR 881

MIP-1 beta, CCL4, murine (mouse)
RC335-15 2ug
EUR 104.38

Rabbit Anti-Mouse Synuclein-gamma antiserum # 1
SYN14-S 100 ul
EUR 457

Anti-Aquaporin 0/MIP Antibody
PA2110 100ug/vial
EUR 294

Anti-Aquaporin 0/MIP Antibody
PB9811 100ug/vial
EUR 294

Anti-MIP-3 alpha Antibody
A00748 100ul
EUR 397
Description: Rabbit Polyclonal Antibody for MIP-3 alpha Antibody (CCL20) detection.tested for IHC in Human, Mouse.

Anti-CXCL2 / MIP-2 antibody
STJ71916 100 µg
EUR 359

anti- MIP-3-beta antibody
FNab05194 100µg
EUR 505.25
Description: Antibody raised against MIP-3-beta

Anti-MIP-3-beta antibody
PAab05194 100 ug
EUR 355

Recombinant Rat GRO-Beta /MIP-2 (CXCL2) Protein
PROTP30348-1 25ug
EUR 317
Description: All three isoforms of GRO are CXC chemokines that can signal through the CXCR1 or CXCR2 receptors. The GRO proteins chemoattract and activate neutrophils and basophils. Recombinant rat GRO-β/MIP-2 is a 7.9 kDa protein consisting of 73 amino acids including the 'ELR' motif common to the CXC chemokine family that bind to CXCR1 or CXCR2.

IFNG Mouse, Interferon-gamma Mouse Recombinant Protein, His Tag
PROTP01580-1 Regular: 20ug
EUR 317
Description: Interferon-gamma Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 158 amino acids (23-155a.a.) and having a molecular mass of 18.2kDa.;IFNG is fused to a 25 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Goat Anti Human Mip-1 Alpha Polyclonal Antibody
CPBT-65207GH 0.1 mg
EUR 881

Rabbit Anti Rat Mip-1 Alpha Polyclonal Antibody
CPBT-65211RR 0.1 mg
EUR 881

Rabbit Anti Human Mip-1 Beta Polyclonal Antibody
CPBT-65212RH 0.1 mg
EUR 881

MIP-1a Macrophage Inflammatory Protein-1 Alpha Human Recombinant Protein (CCL3), His Tag
PROTP10147-1 Regular: 10ug
EUR 317
Description: Macrophage Inflammatory Protein-1 alpha His Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 68 amino acids and having a molecular mass of 7820 Dalton with an amino-terminal hexahistidine tag. ;The MIP-1a-His is purified by proprietary chromatographic techniques.

Human Interferon-gamma (IFN-gamma) AssayMax ELISA Kit
EI1023-1 96 Well Plate
EUR 396

MIP-1? Polyclonal Antibody
ES7128-100ul 100ul
EUR 279
Description: A Rabbit Polyclonal antibody against MIP-1? from Human. This antibody is tested and validated for IHC, WB, ELISA

MIP-1? Polyclonal Antibody
ES7128-50ul 50ul
EUR 207
Description: A Rabbit Polyclonal antibody against MIP-1? from Human. This antibody is tested and validated for IHC, WB, ELISA

MIP-1? Polyclonal Antibody
ES3937-50ul 50ul
EUR 207
Description: A Rabbit Polyclonal antibody against MIP-1? from Human. This antibody is tested and validated for WB, ELISA, WB, ELISA

MIP-1? Polyclonal Antibody
ES3937-100ul 100ul
EUR 279
Description: A Rabbit Polyclonal antibody against MIP-1? from Human. This antibody is tested and validated for WB, ELISA, WB, ELISA

MIP-1 alpha Antibody
20-abx148975
  • EUR 425.00
  • EUR 342.00
  • 100 ug
  • 50 ug

MIP-1 alpha Antibody
45363-100ul 100ul
EUR 252

MIP-1 alpha Antibody
45363-50ul 50ul
EUR 187

MIP- 1 alpha Antibody
ABD8572 100 ug
EUR 438

rHu MIP-1-alpha
AK8250-0005 5µg Ask for price

rHu MIP-1-alpha
AK8250-0020 20µg Ask for price

rHu MIP-1-alpha
AK8250-0100 100µg Ask for price

rHu MIP-1-alpha
AK8250-1000 1mg Ask for price

rHu MIP-1-beta
AK8264-0002 2µg Ask for price

rHu MIP-1-beta
AK8264-0010 10µg Ask for price

rHu MIP-1-beta
AK8264-0100 100µg Ask for price

rHu MIP-1-beta
AK8264-1000 1mg Ask for price

MIP-1 alpha Antibody
DF8572 200ul
EUR 304
Description: MIP-1 alpha Antibody detects endogenous levels of total MIP-1 alpha.

MIP-1-alpha Antibody
5246-100
EUR 338

MIP-1-beta Antibody
5249-100
EUR 338

MIP 1 alpha antibody
20R-1788 100 ug
EUR 673
Description: Rabbit polyclonal MIP 1 alpha antibody

MIP 1 beta antibody
20R-1789 100 ug
EUR 673
Description: Rabbit polyclonal MIP 1 beta antibody

Horse Gamma Globulin
29305-1 1g
EUR 129
Description: Horse gamma globulin is purified from serum obtained from normal healthy animals (male and female) by using various fractionation procedures. It is in lyophilized powder form with purity of 95% or more. Protein by weight: O.D. 280 nm E1%1.39: ? 85% - Residual salts, lipids, etc. comprise the rest of the weight.

Anti-EF-1 gamma antibody
STJ92840 200 µl
EUR 197
Description: Rabbit polyclonal to EF-1 gamma.

Adverse occasions: two small studies reported on mortality; one in every of these additionally reported on severe and different adversarial occasions, however pattern sizes had been too small for small variations to be detected. Therefore, low-quality proof means that the intervention might have little to no impact on mortality and different adversarial occasions. Health-related high quality of life: solely very low-quality proof from one examine is offered. We are unsure whether or not the intervention improves disease-specific high quality of lifetime of sufferers with bronchial asthma. Health-related outcomes: low-quality proof from eight studies means that the intervention might have little to no impact on bronchial asthma management, glycosylated haemoglobin (HbA1c) ranges, blood strain, low-density lipoprotein or whole levels of cholesterol, physique mass index or weight, or 10-year Framingham threat scores.

Low-quality proof from one examine means that the composite scores of threat components for diabetes mellitus might enhance barely with the intervention, however there’s uncertainty about results on ophthalmic medicines or intraocular strain. Psychosocial well being outcomes: no examine investigated psychosocial well being outcomes in a greater than anecdotal means. Health useful resource consumption: low-quality proof for grownup sufferers in three studies means that there could also be little to no impact of the intervention on completely different measures of well beingcare use. Patient-provider communication: very low-quality proof is offered from a single small examine, and we’re unsure whether or not the intervention improves communication measures, such because the variety of messages despatched.

A human factors approach to subcutaneous insulin chart design improves user-performance: An experimental study

by
A human factors approach to subcutaneous insulin chart design improves user-performance: An experimental study

Insulin is a high-risk drugs that has been implicated in critical hostile occasions for hospital inpatients, together with medication-error associated deaths. Most insulin errors happen throughout administration, and “flawed dose” is the most typical kind. A paper-based subcutaneous insulin chart (the “NSIC”) was developed for the Australian Commission on Safety and Quality in Health Care, utilizing a variety of human factors strategies, with the intention of lowering the chance for errors. The current lab-based study empirically assessed whether or not the NSIC’s human factors design interprets into improved user-performance within the willpower of insulin doses, in contrast with a pre-existing chart. Forty-one skilled nurses and 48 novice chart-users accomplished 60 experimental trials (30 per chart), wherein they decided doses to administer to sufferers. Both teams decided insulin doses sooner, and made fewer dose errors, when utilizing the NSIC. These outcomes help the utility of the usability heuristics employed in creating the chart.

Rapid exams have reworked the panorama of available instruments for clinicians caring for sufferers who’re critically ailing. Their emergence as a part of routine care will increase the capability for comparable units to reverse or reduce main epidemics and help well beingcare suppliers of their medical decision-making. To assess how a point-of-care full blood depend (CBC) may change patterns in medical decision-making, we introduced low and center revenue (LMIC) well beingcare suppliers with hypothetical medical situations to perceive how such a tool may affect the way in which they deal with and refer sufferers.

Sensitivity of Molds From Spoiled Dairy Products Towards Bioprotective Lactic Acid Bacteria Cultures

Fungal spoilage of dairy merchandise is a significant concern due to meals waste and economical losses, some fungal metabolites might moreover have hostile results on human well being. The use of lactic acid micro organism (LAB) is rising as a possible clear label different to chemical preservatives. Here, our intention was to characterize the expansion potential at three storage temperatures (5, 16, and 25°C) of a panel of molds (4 Mucor and 9 Penicillium strains) remoted from dairy merchandise, then examine the susceptibility of the molds towards 12 LAB cultures. Fungal cell progress and morphology in malt extract broth was monitored utilizing oCelloScope at 25°C for 24 h. Mucor plumbeus 01180036 was the quickest rising and Penicillium roqueforti ISI4 (P. roqueforti ISI4) the slowest of the examined molds. On yogurt-agar plates, all molds grew at 5, 16, and 25°C in a temperature-dependent method with Mucor strains rising sooner than Penicillium strains no matter temperature. The sensitivity towards 12 LAB cultures was examined utilizing high-throughput overlay technique and right here all of the molds besides P. roqueforti ISI4 had been strongly inhibited.

The antifungal motion of those LAB was confirmed when recognizing mildew spores on agar plates containing stay cells of the LAB strains. However, if cells had been faraway from the fermentates, the inhibitory results decreased markedly. The antifungal results of volatiles examined in a plate-on-plate system with out direct contact between mildew and LAB tradition media had been modest. Some LAB binary combos improved the antifungal exercise towards the expansion of a number of molds past that of single cultures in yogurt serum.

The function of aggressive exclusion due to manganese depletion was examined as a attainable antifungal mechanism for six Penicillium and two Mucor strains. It was proven that this mechanism was a significant inhibition issue for the molds examined aside from the non-inhibited P. roqueforti ISI4 since addition of manganese with growing concentrations of up to 0.1 mM resulted in partly or totally restored mildew progress in yogurt. These findings assist to perceive the parameters influencing the mildew spoilage of dairy merchandise and the interactions between the contaminating strains, substrate, and bioprotective LAB cultures.

A human factors approach to subcutaneous insulin chart design improves user-performance: An experimental study

Sensor-based detection of algal blooms for public well being advisories and long-term monitoring

Throughout the United States, many eutrophic freshwater our bodies expertise seasonal blooms of poisonous cyanobacteria. These blooms restrict leisure makes use of and pose a menace to each human and ecological well being. Traditional bi-weekly chlorophyll-based sampling packages designed to assess total algal biomass fail to seize necessary bloom parameters resembling bloom timing, period, and peak depth. In-situ optical and fluorometric measurements have the potential to fill this hole. However, relating in-situ measurements to related water high quality measures (e.g. cyanobacterial cell density or chlorophyll focus) is a problem that limits the implementation of probe-based monitoring methods.

Anti-Granzyme B antibody
STJ16100751 1 mL
EUR 478

Anti-Granzyme B antibody
STJ16100752 1 mL
EUR 478

Anti-Granzyme B antibody
STJ16101330 1 mL
EUR 774

Anti-Granzyme B antibody
STJ16101466 1 mL
EUR 774

Anti-Granzyme B antibody
STJ180310 0.1 ml
EUR 212

Anti-Granzyme B antibody
STJ180380 0.1 ml
EUR 213

Anti-Granzyme B Antibody
A00353 100ul
EUR 397
Description: Rabbit Polyclonal Granzyme B Antibody. Validated in IHC, WB and tested in Human, Mouse, Rat.

Anti-Granzyme B Purified
11-634-C100 0.1 mg
EUR 195

Anti-Granzyme B antibody
STJ99635 200 µl
EUR 197
Description: Rabbit polyclonal to Granzyme B.